Michael W. Strand & Jonathan H. Watanabe. (2024). Examining the Impact of the World Health Organization 2022 Guidelines on Evaluation of Biosimilars for Non-Local Comparators in Biosimilar Studies on Middle East and North Africa Member States. MDPI AG.
Chicago Style (17th ed.) CitationMichael W. Strand and Jonathan H. Watanabe. Examining the Impact of the World Health Organization 2022 Guidelines on Evaluation of Biosimilars for Non-Local Comparators in Biosimilar Studies on Middle East and North Africa Member States. MDPI AG, 2024.
MLA (9th ed.) CitationMichael W. Strand and Jonathan H. Watanabe. Examining the Impact of the World Health Organization 2022 Guidelines on Evaluation of Biosimilars for Non-Local Comparators in Biosimilar Studies on Middle East and North Africa Member States. MDPI AG, 2024.